|
1.World Health Organization. The stop TB strategy. Geneva, Switzerland: World Health Organization; 2006. WHO/HTM/STB/2006.368 2.Fine PE, Sterne JA, Ponnighaus JM and Rees RJ. Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity. Lancet. 1994;344:1245-1249 3.Pediatric Tuberculosis Collaborative Group. Targeted Tuberculin Skin Testing and Treatment of Latent Tuberculosis Infection in Children and Adolescents. Pediatrics. 2004;114:1175–1201 4.Saiman L, Aronson J, Zhou J, et al. Prevalence of infectious diseases among internationally adopted children. Pediatrics. 2001;108:608-612 5.Almeida LM, Barbieri MA, Da Paixao AC and Cuevas LE. Use of purified protein derivative to assess the risk of infection in children in close contact with adults with tuberculosis in a population with high Calmette-Guerin bacillus coverage. Pediatr Infect Dis J. 2001;20:1061-1065 6.Mudido PM, Guwatudde D, Nakakeeto MK, et al. The effect of bacille Calmette-Guerin vaccination at birth on tuberculin skin test reactivity in Ugandan children. Int J Tuberc Lung Dis. 1999;3:891-395 7.Lockman S, Tappero JW, Kenyon TA, Rumisha D, Huebner RE and Binkin NJ. Tuberculin reactivity in a pediatric population with high BCG vaccination coverage. Int J Tuberc Lung Dis. 1999;3:23-30 8.Fine PE, Bruce J, Ponnighaus JM, Nkhosa P, Harawa A and Vynnycky E. Tuberculin sensitivity: conversions and reversions in a rural African population. Int J Tuberc Lung Dis. 1999;3:962-975 9.Tanzania Tuberculin Survey Collaboration. Tuberculosis control in the era of the HIV epidemic: risk of tuberculosis infection in Tanzania, 1983-1998. Int J Tuberc Lung Dis. 2001;5:103-112 10.Lifschitz M. The value of the tuberculin skin test as a screening test for tuberculosis among BCG-vaccinated children. Pediatrics. 1965;36: 624–627 11.Santiago EM, Lawson E, Gillenwater K, Kalangi S, Lescano AG, Du Quella G, Cummings K, Cabrera L, Torres C, and Gilman RH. A Prospective Study of Bacillus Calmette-Gue´rin Scar Formation and Tuberculin Skin Test Reactivity in Infants in Lima, Peru. Pediatrics. 2003:112;e298-e302 12.World Health Organization. BCG vaccine, WHO position paper. Weekly Epidemiological Record. 2004:4; 27-28 13.Taiwan Provincial Chronic Disease Control Bureau. Chronological Development of the Program, BCG vaccination. A review of the tuberculosis control program in Taiwan: 1949-1989. Taipei, Taiwan: Taiwan Provincial Chronic Disease Control Bureau; 1991 14.Taiwan Centers for Disease Control. Strategies for Tuberculosis Control. Tuberculosis Annual Report: 2001. Taipei, Taiwan: Taiwan Centers for Disease Control; 2001 15.Loeffler AM. Pediatric tuberculosis. Seminars in Respiratory Infections. 2003:18;272-291 16.World Health Organization. Guideline for national tuberculosis programs on the management of tuberculosis in children. Geneva, Switzerland: World Health Organization; 2006. WHO/HTM/STB/2006.371 17.Jasmer RM, Nahid P, Hopewell PC. Latent tuberculosis infection. N Eng J Med. 2002; 347: 1860-1866 18.Bowerman RJ. Tuberculin skin testing in BCG-vaccinated populations of adults and children at high risk for tuberculosis in Taiwan. Int J Tuberc Lung Dis. 2004;8:1228-1233 19.Marcus JH, Khassis Y. The tuberculin sensitivity in BCG vaccinated infants and children in Israel. Acta Tuberc Pneumol Scand. 1965;46:113–122 20.Comstock GW, Edwards LB, Nabangxang H. Tuberculin sensitivity eight to fifteen years after BCG Vaccination. Am Rev Respir Dis. 1971;103:572–575 21.Horwitz O, Bunch-Christensen K. Correlation between tuberculin sensitivity after 2 months and 5 years among BCG vaccinated subjects. Bull World Health Organ. 1972;47:49–58 22.Sepulveda RL, Burr C, Ferrer X and Sorensen RU. Booster effect of tuberculin testing in healthy 6-year-old school children vaccinated with Bacillus Calmette-Guerin at birth in Santiago, Chile. Pediatr Infect Dis J. 1988;7:578-581 23.Menzies R, Vissandjee B. Effect of bacille Calmette-Guerin vaccination on tuberculin reactivity. Am Rev Respir Dis. 1992;145:621–625 24.Al-Kassimi FA, Abdullah AK, al-Orainey IO, et al. The significance of positive Mantoux reactions in BCG-vaccinated children. Tubercle. 1991;72:101–104 25.Yeh YP, Luh DL, Chang SH, Suo J, Chang HJ, Chen THH. Tuberculin reactivity in adults after 50 years of universal bacilli calmette-Guerin vaccination in Taiwan. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2005;99: 509-516 26.Taiwan Provincial Chronic Disease Control Bureau. Statistics. Taipei, Taiwan: Taiwan Provincial Chronic Disease Control Bureau; 1997 27.Taiwan Centers for Disease Control. Manual of tuberculosis control. Available: http://203.65.72.43/feng/edu/index-1.htm 28.Styblo K. The relationship between the risk of tuberculosis infection and the risk of developing infectious tuberculosis. Bull int Union Tuberc. 1985;60:117–9 29.Arnadottir H, Reider HL, Trebucq A, et al. Guidelines for conducting tuberculin skin test surveys in high prevalence countries. Tuberc Lung Dis. 1996;77 (Suppl.):1–20 30.American Academy of Pediatrics. Red book: 2006 Report of the Committee on Infectious Diseases. 27th ed. Elk Groove Village, IL: American Academy of Pediatrics; 2006:678-685 31.Grzybowski S, Barnett GD, Styblo K. Contacts of cases of active pulmonary tuberculosis. Bull Int Union Tuberc. 1975;50(1):90–106 32.Wang L, Turner MO, Elwood RK, Schulzer M and FitzGerald JM. A meta-analysis of the effect of Bacille Calmette Guerin vaccination on tuberculin skin test measurements. Thorax. 2002;57:804-809 33.Mazurek GH, Villarino ME. Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection. Centers for Disease Control and Prevention. MMWR Recomm Rep. 2003;52:15-18 34.Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B, Vernon A. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep. 2005; 54: 49–55 35.Lalvani A, Pathan AA, Durkan H, et al. Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet. 2001;357:2017-2021 36.Ewer K, Deeks J, Alvarez L, et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet. 2003;361:1168-1173 37.Karalliedde S, Katugaha LP and Uragoda CG. Tuberculin response of Sri Lankan children after BCG vaccination at birth. Tubercle. 1987;68:33-38 38.Kang YA, Lee HW, Yoon HI, Cho BL, Han SK, Shim YS, Yim JJ. Discrepancy Between the Tuberculin Skin Test and the Whole-Blood Interferon γ Assay for the Diagnosis of Latent Tuberculosis Infection in an Intermediate Tuberculosis-Burden Country. JAMA. 2005: 293;2756-2761 39.Ewer K, Deeks J, Alvarez L, Bryant G, Waller S, Andersen P, Monk P, Lalvani A. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet. 2003; 361: 1168–1173 40.Soysal A, Millington KA, Bakir M, Dosanjh D, Aslan Y, Deeks JJ, Efe S, Staveley I, Ewer K, Lalvani A. Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study. Lancet. 2005; 366: 1443–1451 41.Comstock GW, Edwards LB, Philip RN, Winn WA. A comparison in the United States of America of two tuberculins, PPD-S and PPD RT 23. Bull World Health Organ. 1964;31:161–170 42.Leung CC, Yew WW, Tam CM, Chan CK, Chang KC, Law WS, Lee SN, Wong MY, Au KF. Tuberculin response in BCG vaccinated schoolchildren and the estimation of annual risk of infection in Hong Kong. Thorax. 2005:60;124-129 43.Chee CBE, Soh CH, Boudville IC, Chor SS, Wang YT. Interpretation of the Tuberculin Skin Test in Mycobacterium bovis BCG-vaccinated Singaporean Schoolchildren. Am J Respir Crit Care. 2001:164; 958–961
|